STARTUP PROFILE

Spiro Medical

COUNTRY
USA
FOUNDED
2023
CATEGORY
Neuromodulation
Developing an implantable pulmonary neuromodulation system for severe asthma, targeting airway neural reflex pathways through bioelectronic intervention.
Visit website →
Neurofounders Insights
$   Funding   -
Series A
MODALITY
Nerve stimulator
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Other
TARGET USER
Patients
REGULATORY STAGE
Investigational
Spiro Medical sits at the edge of bioelectronic medicine and respiratory care, applying implantable neuromodulation to severe asthma. Its positioning is strategically notable because it extends neural control approaches into pulmonary disease, where device-based therapy remains a more specialized category.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Spiro Medical
No items found.